Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck

NCT01283906 is registered in ClinicalTrials.gov with Access Pharmaceuticals, Inc. as lead sponsor.

NCT NCT01283906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01283906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck
Lead sponsor
Access Pharmaceuticals, Inc.
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2011
Completion date
May 31, 2013
Enrollment
120 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

oral mucositis